BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 15596372)

  • 1. Neural network approach to the segmentation and classification of dynamic magnetic resonance images of the breast: comparison with empiric and quantitative kinetic parameters.
    Szabó BK; Aspelin P; Wiberg MK
    Acad Radiol; 2004 Dec; 11(12):1344-54. PubMed ID: 15596372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Combination of low and high resolution T1-weighted sequences for improved evaluation of morphologic criteria in dynamic contrast enhanced MRI of the breast].
    Vomweg TW; Teifke A; Schreiber WG; Schmidt M; Thelen M
    Rofo; 2002 Nov; 174(11):1445-9. PubMed ID: 12424673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative 2- and 3-dimensional analysis of pharmacokinetic model-derived variables for breast lesions in dynamic, contrast-enhanced MR mammography.
    Hauth EA; Jaeger HJ; Maderwald S; Muehler A; Kimmig R; Forsting M
    Eur J Radiol; 2008 May; 66(2):300-8. PubMed ID: 17658235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Equilibrium signal intensity mapping, an MRI method for fast mapping of longitudinal relaxation rates and for image enhancement.
    Surányi P; Kiss P; Ruzsics B; Brott BC; Simor T; Elgavish GA
    Magn Reson Imaging; 2007 Jun; 25(5):641-51. PubMed ID: 17540275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced mass on contrast-enhanced breast MR imaging: Lesion characterization using combination of dynamic contrast-enhanced and diffusion-weighted MR images.
    Yabuuchi H; Matsuo Y; Okafuji T; Kamitani T; Soeda H; Setoguchi T; Sakai S; Hatakenaka M; Kubo M; Sadanaga N; Yamamoto H; Honda H
    J Magn Reson Imaging; 2008 Nov; 28(5):1157-65. PubMed ID: 18972357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feature extraction and classification of dynamic contrast-enhanced T2*-weighted breast image data.
    Torheim G; Godtliebsen F; Axelson D; Kvistad KA; Haraldseth O; Rinck PA
    IEEE Trans Med Imaging; 2001 Dec; 20(12):1293-301. PubMed ID: 11811829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reproducibility of the aortic input function (AIF) derived from dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) of the kidneys in a volunteer study.
    Mendichovszky IA; Cutajar M; Gordon I
    Eur J Radiol; 2009 Sep; 71(3):576-81. PubMed ID: 19004588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Free-breathing quantitative dynamic contrast-enhanced magnetic resonance imaging in a rat liver tumor model using dynamic radial T(1) mapping.
    Braren R; Curcic J; Remmele S; Altomonte J; Ebert O; Rummeny EJ; Steingoetter A
    Invest Radiol; 2011 Oct; 46(10):624-31. PubMed ID: 21577121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic approach for dynamic breast MRI to indicate signal intensity time curves of benign and malignant lesions by using the tumor flow residence time.
    Renz DM; Diekmann F; Schmitzberger FF; Pietsch H; Fallenberg EM; Durmus T; Huppertz A; Böttcher J; Bick U; Hamm B; Lawaczeck R
    Invest Radiol; 2013 Feb; 48(2):69-78. PubMed ID: 23262793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantification of dynamic contrast-enhanced MR imaging of the knee in children with juvenile rheumatoid arthritis based on pharmacokinetic modeling.
    Workie DW; Dardzinski BJ; Graham TB; Laor T; Bommer WA; O'Brien KJ
    Magn Reson Imaging; 2004 Nov; 22(9):1201-10. PubMed ID: 15607091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relating dose of contrast media administered to uptake and washout of malignant lesions on DCEMRI of the breast.
    Jansen SA; Fan X; Yang C; Shimauchi A; Karczmar G; Newstead GM
    Acad Radiol; 2010 Jan; 17(1):24-30. PubMed ID: 19836270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are signal intensity and homogeneity useful parameters for distinguishing between benign and malignant soft tissue masses on MR images? Objective evaluation by means of texture analysis.
    Mayerhoefer ME; Breitenseher M; Amann G; Dominkus M
    Magn Reson Imaging; 2008 Nov; 26(9):1316-22. PubMed ID: 18448302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant-lesion segmentation using 4D co-occurrence texture analysis applied to dynamic contrast-enhanced magnetic resonance breast image data.
    Woods BJ; Clymer BD; Kurc T; Heverhagen JT; Stevens R; Orsdemir A; Bulan O; Knopp MV
    J Magn Reson Imaging; 2007 Mar; 25(3):495-501. PubMed ID: 17279534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of prostate DCE-MRI: comparison of fast exchange limit and fast exchange regimen pharmacokinetic models in the discrimination of malignant from normal tissue.
    Lowry M; Zelhof B; Liney GP; Gibbs P; Pickles MD; Turnbull LW
    Invest Radiol; 2009 Sep; 44(9):577-84. PubMed ID: 19668002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between lesion size and signal enhancement on subtraction fat-suppressed MR imaging of the breast.
    Cheung HS; Tse GM; Lai SY; Yeung DK
    Magn Reson Imaging; 2004 Nov; 22(9):1259-64. PubMed ID: 15607097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the three-time-point method for diagnosis of breast lesions in contrast-enhanced MR mammography.
    Hauth EA; Stockamp C; Maderwald S; Mühler A; Kimmig R; Jaeger H; Barkhausen J; Forsting M
    Clin Imaging; 2006; 30(3):160-5. PubMed ID: 16632149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis of breast tumors by contrast-enhanced MR imaging: comparison between the diagnostic performance of dynamic enhancement patterns and morphologic features.
    Goto M; Ito H; Akazawa K; Kubota T; Kizu O; Yamada K; Nishimura T
    J Magn Reson Imaging; 2007 Jan; 25(1):104-12. PubMed ID: 17152054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of dynamic phase subtraction (DPS) map in dynamic contrast-enhanced MRI of the breast.
    Ogura A; Hayakawa K; Yoshida S; Maeda F; Saeki F; Syukutani A
    J Comput Assist Tomogr; 2011; 35(6):749-52. PubMed ID: 22082548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic contrast enhanced MRI in the differential diagnosis of adrenal adenomas and malignant adrenal masses.
    Inan N; Arslan A; Akansel G; Anik Y; Balci NC; Demirci A
    Eur J Radiol; 2008 Jan; 65(1):154-62. PubMed ID: 17466481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancing lesions of the brain: intraindividual crossover comparison of contrast enhancement after gadobenate dimeglumine versus established gadolinium comparators.
    Essig M; Tartaro A; Tartaglione T; Pirovano G; Kirchin MA; Spinazzi A
    Acad Radiol; 2006 Jun; 13(6):744-51. PubMed ID: 16679277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.